Yingli Zhang

1 Banshan East Road
Hangzhou, 310022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial.

Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trial.

Journal: Journal of gynecologic oncology

Published: January 26, 2026

Tisotumab vedotin versus chemotherapy in Chinese patients with recurrent or metastatic cervical cancer with disease progression on or after systemic therapy.

Tisotumab vedotin versus chemotherapy in Chinese patients with recurrent or metastatic cervical cancer with disease progression on or after systemic therapy.

Journal: Chinese medical journal

Published: September 22, 2025

Uncovering ShuangZi Powder's Anti-Ovarian Cancer Mechanism: A Systems Biology and Experimental Approach.

Uncovering ShuangZi Powder's Anti-Ovarian Cancer Mechanism: A Systems Biology and Experimental Approach.

Journal: Combinatorial chemistry & high throughput screening

Published: April 08, 2025

The effects of synbiotics surpass prebiotics in improving inflammatory biomarkers in children and adults: A systematic review, meta-analysis, and meta-evidence of data from 5207 participants in 90 randomized controlled trials.

The effects of synbiotics surpass prebiotics in improving inflammatory biomarkers in children and adults: A systematic review, meta-analysis, and meta-evidence of data from 5207 participants in 90 randomized controlled trials.

Journal: Pharmacological research

Published: April 03, 2025

Therapeutically targeting endometrial cancer in preclinical models by ICAM1 antibody-drug conjugates.

Therapeutically targeting endometrial cancer in preclinical models by ICAM1 antibody-drug conjugates.

Journal: Gynecologic oncology

Published: January 10, 2025

Characteristics and potential diagnostic value of gut microbiota in ovarian tumor patients.

Characteristics and potential diagnostic value of gut microbiota in ovarian tumor patients.

Journal: Scientific reports

Published: December 04, 2024

Shanghai Gynecologic Oncology Group's consensus on the academic and industry's clinical trial types.

Shanghai Gynecologic Oncology Group's consensus on the academic and industry's clinical trial types.

Journal: Chinese medical journal

Published: February 02, 2024

Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China.

Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China.

Journal: Targeted oncology

Published: September 05, 2023

Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer.

Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer.

Journal: Current cancer drug targets

Published: August 29, 2023

The impact of different clinicopathologic factors and salvage therapies on cervical cancer patients with isolated para-aortic lymph node recurrence.

The impact of different clinicopathologic factors and salvage therapies on cervical cancer patients with isolated para-aortic lymph node recurrence.

Journal: Discover oncology

Published: August 05, 2023

Prognostic factors of patients with recurrent uterine malignancies undergoing secondary cytoreductive surgery.

Prognostic factors of patients with recurrent uterine malignancies undergoing secondary cytoreductive surgery.

Journal: BMC women's health

Published: April 01, 2023

A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept.

A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept.

Journal: BMC cancer

Published: October 29, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026